# The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions

> **NCT06228339** · PHASE1 · UNKNOWN · sponsor: **International Bio service** · enrollment: 44 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets
- **DRUG:** Xatral® XL 10 mg

## Key facts

- **NCT ID:** NCT06228339
- **Lead sponsor:** International Bio service
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-09
- **Primary completion:** 2024-03-14
- **Final completion:** 2024-03-21
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06228339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06228339, "The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06228339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*